Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision tag is shown (v3.6.5), replacing the prior v3.6.4, indicating a backend update to the site without changes to the study data or visible content.
    Difference
    0.1%
    Check dated 2026-08-08T11:17:38.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Removes the sponsor attribution, a document descriptor, and a navigation header in the Study Documents area. This reduces visible context and access to study materials for the page.
    Difference
    0.2%
    Check dated 2026-08-01T10:37:35.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, indicating a newer site build; Revision: v3.6.3 is removed from the display.
    Difference
    0.1%
    Check dated 2026-07-25T06:21:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3 instead of v3.6.2, indicating a small maintenance/version update to the page's metadata. This does not modify the substantive study content.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays the site revision as v3.6.2, indicating a deployment update. This change does not modify the displayed study details.
    Difference
    0.1%
    Check dated 2026-06-26T19:34:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was standardized and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:03.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.